Literature DB >> 9111334

Nuclear receptor corepressors activate rather than suppress basal transcription of genes that are negatively regulated by thyroid hormone.

T Tagami1, L D Madison, T Nagaya, J L Jameson.   

Abstract

A group of transcriptional cofactors referred to as corepressors (CoRs) were recently shown to play a central role in basal silencing of genes that contain positive triiodothyronine (T3) response elements. In a reciprocal manner, negatively regulated genes are stimulated by unliganded thyroid hormone receptor (TR) and repressed upon the addition of T3. We used a TR beta mutant, called P214R, which fails to interact with CoRs, to examine whether CoRs also play a role in the control of genes that are negatively regulated in response to T3. In studies of three negatively regulated genes (the pituitary thyroid-stimulating hormone alpha-subunit [TSH alpha], TSH beta, and hypothalamic thyrotropin-releasing hormone [TRH] genes), stimulation of basal promoter activity by unliganded TR beta was impaired by introducing the P214R CoR mutation. Coexpression of each of the CoRs SMRT (silencing mediator for retinoid receptors and TRs) and NCoR (nuclear receptor CoR) enhanced basal stimulation of the negatively regulated promoters in a TR-dependent manner, but this effect was not seen with the P214R TR mutant. The mechanism of CoR effects on negatively regulated promoters was explored further with a series of GAL4-TR chimeric receptors and mutants that allowed TR effects to be assessed independently of receptor interactions with DNA. These experiments revealed that, like the negative regulation of genes by wild-type TR, basal activation occurred with GAL4-TR, but not with the GAL4-P214R mutant, and was reversed by the addition of T3. These results suggest that TR interactions with negatively regulated genes may be driven through protein-protein interactions. We conclude that a subset of negatively regulated genes are controlled by a novel mechanism that involves TR-mediated recruitment and basal activation by SMRT and NCoR. Addition of T3 reverses basal activation, perhaps by dissociation of CoRs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9111334      PMCID: PMC232114          DOI: 10.1128/MCB.17.5.2642

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  39 in total

1.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

2.  Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor.

Authors:  A J Hörlein; A M Näär; T Heinzel; J Torchia; B Gloss; R Kurokawa; A Ryan; Y Kamei; M Söderström; C K Glass
Journal:  Nature       Date:  1995-10-05       Impact factor: 49.962

3.  The tau 4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing.

Authors:  A Baniahmad; X Leng; T P Burris; S Y Tsai; M J Tsai; B W O'Malley
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

4.  Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor.

Authors:  J W Lee; H S Choi; J Gyuris; R Brent; D D Moore
Journal:  Mol Endocrinol       Date:  1995-02

Review 5.  Nomenclature of thyroid hormone receptor beta-gene mutations in resistance to thyroid hormone: consensus statement from the first workshop on thyroid hormone resistance, July 10-11, 1993, Cambridge, United Kingdom.

Authors:  P Beck-Peccoz; V K Chatterjee; W W Chin; L J DeGroot; J L Jameson; H Nakamura; S Refetoff; S J Usala; B D Weintraub
Journal:  J Clin Endocrinol Metab       Date:  1994-04       Impact factor: 5.958

6.  Ligand (T3) dependent and independent effects of thyroid hormone receptors upon human TRH gene transcription in neuroblastoma cells.

Authors:  P Feng; Q L Li; T Satoh; J F Wilber
Journal:  Biochem Biophys Res Commun       Date:  1994-04-15       Impact factor: 3.575

7.  Functional analysis of a transactivation domain in the thyroid hormone beta receptor.

Authors:  Y Tone; T N Collingwood; M Adams; V K Chatterjee
Journal:  J Biol Chem       Date:  1994-12-09       Impact factor: 5.157

8.  Polarity-specific activities of retinoic acid receptors determined by a co-repressor.

Authors:  R Kurokawa; M Söderström; A Hörlein; S Halachmi; M Brown; M G Rosenfeld; C K Glass
Journal:  Nature       Date:  1995-10-05       Impact factor: 49.962

9.  Ligand-independent and -dependent functions of thyroid hormone receptor isoforms depend upon their distinct amino termini.

Authors:  A N Hollenberg; T Monden; F E Wondisford
Journal:  J Biol Chem       Date:  1995-06-16       Impact factor: 5.157

10.  Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity.

Authors:  B Durand; M Saunders; C Gaudon; B Roy; R Losson; P Chambon
Journal:  EMBO J       Date:  1994-11-15       Impact factor: 11.598

View more
  42 in total

Review 1.  Resistance to thyroid hormone.

Authors:  R E Weiss; S Refetoff
Journal:  Rev Endocr Metab Disord       Date:  2000-01       Impact factor: 6.514

Review 2.  Thyroid hormone suppression of pituitary hormone gene expression.

Authors:  M A Shupnik
Journal:  Rev Endocr Metab Disord       Date:  2000-01       Impact factor: 6.514

3.  Androgen receptor repression of GnRH gene transcription.

Authors:  Melissa J Brayman; Patricia A Pepa; Sara E Berdy; Pamela L Mellon
Journal:  Mol Endocrinol       Date:  2011-11-10

4.  Transcriptional regulation of the human glycoprotein hormone common alpha subunit gene by cAMP-response-element-binding protein (CREB)-binding protein (CBP)/p300 and p53.

Authors:  Xian Zhang; Roger J A Grand; Christopher J McCabe; Jayne A Franklyn; Phillip H Gallimore; Andrew S Turnell
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

Review 5.  Thyroid hormone action: a binding contract.

Authors:  Mitchell A Lazar
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

6.  Thyroid hormone action in the absence of thyroid hormone receptor DNA-binding in vivo.

Authors:  Nobuyuki Shibusawa; Koshi Hashimoto; Amisra A Nikrodhanond; M Charles Liberman; Meredithe L Applebury; Xiao Hui Liao; Janet T Robbins; Samuel Refetoff; Ronald N Cohen; Fredric E Wondisford
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

7.  Thyroid-hormone-dependent negative regulation of thyrotropin beta gene by thyroid hormone receptors: study with a new experimental system using CV1 cells.

Authors:  Keiko Nakano; Akio Matsushita; Shigekazu Sasaki; Hiroko Misawa; Kozo Nishiyama; Yumiko Kashiwabara; Hirotoshi Nakamura
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

8.  Repression of cardiac phospholamban gene expression is mediated by thyroid hormone receptor-{alpha}1 and involves targeted covalent histone modifications.

Authors:  Madesh Belakavadi; Jason Saunders; Noah Weisleder; Preethi S Raghava; Joseph D Fondell
Journal:  Endocrinology       Date:  2010-04-14       Impact factor: 4.736

9.  Retinoic acid repression of bone morphogenetic protein 4 in inner ear development.

Authors:  Deborah L Thompson; Lisa M Gerlach-Bank; Kate F Barald; Ronald J Koenig
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

10.  Negative regulation by thyroid hormone receptor requires an intact coactivator-binding surface.

Authors:  Tania M Ortiga-Carvalho; Nobuyuki Shibusawa; Amisra Nikrodhanond; Karen J Oliveira; Danielle S Machado; Xiao-Hui Liao; Ronald N Cohen; Samuel Refetoff; Fredric E Wondisford
Journal:  J Clin Invest       Date:  2005-08-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.